Optimize your metabolism — Save up to $400 on initial treatments! Claim Offer
State-Certified Compounding Facilities
Nationwide Clinical Network
Cold-Chain Medication Logistics
24-Hour Medical Clearances
State-Certified Compounding Facilities
Nationwide Clinical Network
Cold-Chain Medication Logistics
24-Hour Medical Clearances
← Back to News
DH

Daniel Hartley, MS

Pharmacology & Drug Science Writer

About Daniel Hartley

Daniel Hartley is a pharmacology writer who explains how weight loss medications work at the molecular level — and why that matters for the people taking them. He holds a Master of Science in Pharmacology from Georgetown University, where his thesis research examined GLP-1 receptor signaling pathways and their downstream effects on appetite regulation and glucose homeostasis. Before becoming a writer, Daniel spent four years as a bench scientist in a peptide therapeutics research lab, synthesizing and characterizing GLP-1 receptor agonist analogs. He understands these drugs not as brand names on a prescription pad but as engineered molecules with specific binding affinities, half-lives, and pharmacokinetic profiles — and he writes with that precision.

After leaving the bench, Daniel transitioned into pharmaceutical medical affairs, where he spent three years writing clinical summaries, mechanism-of-action documents, and medical information response letters for cardiometabolic drug programs. He worked across multiple product launches in the GLP-1 and dual GIP/GLP-1 agonist space, giving him a front-row seat to the clinical development pipeline that has since reshaped obesity treatment. It was during this period that he realized the explanatory content reaching patients bore almost no resemblance to the science he was writing internally — the mechanism-of-action sections on consumer health websites were vague, often inaccurate, and almost never cited primary pharmacology literature. He began writing for general audiences to fix that.

At Losing Weight RX, Daniel is the go-to author for pharmacology deep dives. He writes the site's mechanism-of-action explainers, drug interaction guides, and pharmacokinetic breakdowns — the content that answers "how does this drug actually work in my body?" with real science instead of marketing copy. He is a member of the American Society for Pharmacology and Experimental Therapeutics and the Drug Information Association, and he maintains active engagement with published pharmacology literature. His writing is technical but never impenetrable — he believes that patients who understand the pharmacology of their medication are better equipped to use it safely, ask informed questions, and recognize when something isn't right.

Articles by Daniel Hartley

FDA Peptide Rules Restrict Sermorelin Access

FDA Peptide Rules Restrict Sermorelin Access

May 29, 2026
NIH Study Explains Why GLP-1 Weight Loss Plateaus Happen

NIH Study Explains Why GLP-1 Weight Loss Plateaus Happen

May 29, 2026